DK1165071T3 - Forbedret cancerbehandling med temozolomid - Google Patents

Forbedret cancerbehandling med temozolomid

Info

Publication number
DK1165071T3
DK1165071T3 DK00918435T DK00918435T DK1165071T3 DK 1165071 T3 DK1165071 T3 DK 1165071T3 DK 00918435 T DK00918435 T DK 00918435T DK 00918435 T DK00918435 T DK 00918435T DK 1165071 T3 DK1165071 T3 DK 1165071T3
Authority
DK
Denmark
Prior art keywords
temozolomide
cancer treatment
improved cancer
improved
treatment
Prior art date
Application number
DK00918435T
Other languages
English (en)
Inventor
Mohamed H Ragab
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK1165071T3 publication Critical patent/DK1165071T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK00918435T 1999-03-30 2000-03-27 Forbedret cancerbehandling med temozolomid DK1165071T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28134899A 1999-03-30 1999-03-30

Publications (1)

Publication Number Publication Date
DK1165071T3 true DK1165071T3 (da) 2006-02-20

Family

ID=23076905

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00918435T DK1165071T3 (da) 1999-03-30 2000-03-27 Forbedret cancerbehandling med temozolomid

Country Status (18)

Country Link
EP (1) EP1165071B1 (da)
JP (2) JP2002540148A (da)
CN (2) CN102160864A (da)
AR (1) AR023185A1 (da)
AT (1) ATE310515T1 (da)
AU (1) AU780892B2 (da)
BR (1) BR0009380A (da)
CA (1) CA2368614C (da)
DE (1) DE60024243T2 (da)
DK (1) DK1165071T3 (da)
ES (1) ES2251987T3 (da)
HK (1) HK1044111B (da)
HU (1) HUP0200805A3 (da)
NO (1) NO330651B1 (da)
NZ (1) NZ536302A (da)
TW (1) TWI276434B (da)
WO (1) WO2000057867A2 (da)
ZA (1) ZA200107736B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100366249C (zh) * 2002-09-29 2008-02-06 天津帝士力投资控股集团有限公司 一种替莫唑胺控释给药系统
CN1742723A (zh) * 2004-09-02 2006-03-08 天津倍方科技发展有限公司 含有替莫唑胺－8－羧酸酯的药物组合物以及该类化合物用于制备抗肿瘤药物的用途
CN1299772C (zh) * 2004-10-14 2007-02-14 孔庆忠 一种抗癌药物组合物
AU2005304672B2 (en) * 2004-11-09 2010-03-11 Schering Corporation Improved dosing regimen of temozolomide for treating cancer based on the patient's MGMT level
EP2329818A1 (en) * 2006-01-17 2011-06-08 Abbott Laboratories Combination therapy with PARP inhibitors
PE20120254A1 (es) * 2006-04-05 2012-03-26 Opko Health Inc Formulaciones farmaceuticas de sales de 8-[1-(3,5-bis-(trifluorometil)fenil)-etoximetil]-8-fenil-1,7-diaza-espiro[4,5]decan-2-ona
AR061618A1 (es) * 2006-06-26 2008-09-10 Schering Corp Formas de dosificacion unitaria de temozolomida
WO2008022535A1 (fr) * 2006-08-09 2008-02-28 Tian Jin Tasly Group Co., Ltd. Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
AU2007301686B2 (en) * 2006-09-29 2013-02-14 Cipla Limited An improved process for the preparation of temozolomide and analogs
US20140005160A1 (en) * 2010-12-01 2014-01-02 Hooshmand SHESHBARADARAN Method for Treating Refractory Cancer
CN102526038B (zh) * 2011-01-12 2013-09-11 北京人福军威医药技术开发有限公司 替莫唑胺的脑靶向药物组合物及其应用
CN107397735B (zh) * 2017-07-28 2020-07-10 东曜药业有限公司 一种替莫唑胺药物组合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0859630B1 (en) * 1995-10-04 2002-12-11 Schering Corporation Combination of temozolomide and alpha-ifn for the treatment of advanced cancer
CA2184545A1 (en) * 1996-07-31 1998-02-01 Pascale Reidenberg Cancer treatment with temozolomide
CA2184546A1 (en) * 1996-07-31 1998-02-01 Margaret H. Dugan Method for treating pediatric high grade astrocytoma including brain stem glioma

Also Published As

Publication number Publication date
AR023185A1 (es) 2002-09-04
CN1345240A (zh) 2002-04-17
WO2000057867A3 (en) 2001-04-19
HUP0200805A3 (en) 2004-07-28
TWI276434B (en) 2007-03-21
CN102160864A (zh) 2011-08-24
ATE310515T1 (de) 2005-12-15
EP1165071B1 (en) 2005-11-23
HK1044111A1 (en) 2002-10-11
CA2368614C (en) 2008-07-22
NO20014725D0 (no) 2001-09-28
HUP0200805A2 (hu) 2002-07-29
ZA200107736B (en) 2003-02-26
BR0009380A (pt) 2001-12-26
JP2002540148A (ja) 2002-11-26
DE60024243T2 (de) 2006-08-17
ES2251987T3 (es) 2006-05-16
NO330651B1 (no) 2011-05-30
JP2007169297A (ja) 2007-07-05
AU3924400A (en) 2000-10-16
WO2000057867A2 (en) 2000-10-05
NZ536302A (en) 2006-05-26
AU780892B2 (en) 2005-04-21
EP1165071A2 (en) 2002-01-02
DE60024243D1 (de) 2005-12-29
HK1044111B (zh) 2006-02-24
NO20014725L (no) 2001-11-13
CA2368614A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
NO20021400L (no) Terapeutiske kinazolinderivater
DK1637127T3 (da) Terapeutisk mikroskum
IL152754A0 (en) Quinazoline derivatives for the treatment of tumours
FI20000863A (fi) Uusi hoitomenetelmä
EE200200571A (et) Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
AR028476A1 (es) Tratamiento del cancer
DE60017816D1 (de) Herzschrittmacher
NO20022245L (no) Onkolyttiske kombinasjoner for behandling av cancer
NO20020358D0 (no) Anvendelse av etodolac for behandling av kreft
DK1165071T3 (da) Forbedret cancerbehandling med temozolomid
DE60016600D1 (de) Herzschrittmacher
EE200200577A (et) Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
EE200200511A (et) Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks
DE59911113D1 (de) Herzschrittmacher
NO20013596D0 (no) Slambehandling
DE69916133D1 (de) Elektro-neuro-adaptiver stimulator
DE60022086D1 (de) Wasserbehandlung
DE60013608D1 (de) Herzschrittmacher
DE60016452D1 (de) Herzschrittmacher
DE29905089U1 (de) Behandlungsliege
DE59908327D1 (de) Verformungskörper
SI1165071T1 (sl) Izboljsano zdravljenje raka s temozolomidom
NO20014850L (no) CML-terapi
DK1043026T3 (da) Melanombehandling
SE9903421D0 (sv) Behandlingsförfarande